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Abstract
Background:  Homeodomain proteins play critical roles in shaping the development of the
embryonic central nervous system in mammals. After birth, neurogenic activities are relegated to
stem cell niches, which include the subgranular layer of the dentate gyrus of the hippocampus.
Here, we have analyzed the function of HOP (Homeodomain only protein) in this stem cell niche
and in human glioblastomas.
Results: We find that HOP is strongly expressed by radial astrocytes of the dentate gyrus in mice,
which are stem cells that give rise to hippocampal granular neurons throughout adulthood.
Deletion or down-regulation of HOP results in a decrease of apoptosis of these stem cells without
changes in proliferation, and in an increase in the number of newly formed granule neurons. We
also find that human glioblastomas largely lack HOP expression and that reintroduction of HOP
function in glioma cells cultured as gliomaspheres leads to enhanced apoptosis in a subset of cases.
In these cells, HOP function decreases clonogenicity.
Conclusion: These data suggest that HOP participates in the regulation of the adult mouse
hippocampal stem cell niche by negatively affecting cell survival. In addition, HOP may work as a
tumor suppressor in a subset of glioblastomas. HOP function thus appears to be critical in the adult
brain in a region of continued plasticity, and its deregulation may contribute to disease.
Background
HOP (Homeodomain only protein; NM-175606) is a
small 73 amino acid atypical homeodomain protein,
composed simply of a homeodomain. HOP was first
identified in the developing heart where it modulates car-
diac growth [1,2]. Surprisingly, for a homeodomain pro-
tein, HOP cannot bind DNA but exerts its action by
interacting with Serum responsive factor (SRF) and block-
ing its transcriptional activity. This interaction was pro-
posed to regulate the balance between cardiomyocyte
proliferation and differentiation. In addition, HOP was
described as a tumor suppressor gene, as its expression is
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lost or low in lung cancer [3], head and neck squamous
cell carcinoma [4], and choriocarcinoma, where its re-
expression can inhibit cancer growth [5].
In the initial reports describing HOP in the heart, its
expression was also detected in the developing neural
tube and in the adult brain [1,2]. This, as well as its role as
a regulator of differentiation in the heart, prompted us to
assess a role for HOP in adult neurogenesis. Stem cell
niches in the mouse forebrain's subventricular zone (SVZ)
and the subgranular layer (SGL) of the dentate gyrus (DG)
add new neurons to the olfactory bulb and the hippocam-
pus, respectively, in a sustained manner. These processes
are tightly regulated [6,7]. Cell death has been shown to
be essential in the selection of newly formed neurons in
the olfactory bulb [8,9] and DG [10,11]. However, even
though apoptosis is an essential regulator of embryonic
stem cell number [12,13] and despite the presence of
apoptotic cells in both the SVZ and SGL [14], little is
known about the regulation of apoptosis in adult stem
cell niches.
Cell lineages in these niches have been described [15-17].
In the DG, the progenitors of new neurons are SGL radial
astrocytes (called B or type 1 cells) [18,19]. These cells
characteristically extend one or several radial processes
across the entire granule cell layer, self-renew and give rise
to immature intermediate precursors (D or type 2 cells),
which divide and then mature into granule cells. Here, we
show that HOP is expressed by radial astrocytic stem cells
and increases neuronal production by promoting apopto-
sis of these cells.
It has been suggested that gliomas in general, and gliob-
lastomas (GBMs) in particular, derive from the transfor-
mation of neural stem cells [20-22], which may give rise
to cancer stem cells. These cells are rare tumor cells that
self-renew, are tumorigenic and may be responsible for
tumor maintenance, recurrence and possibly metastasis.
Since cell death is crucially involved in the regulation of
tumor formation and since normal brain stem cells and
glioma stem cells share common regulatory mechanisms,
we investigated a role for HOP in GBMs.
We show that HOP is down-regulated in GBMs. Its re-
expression induces apoptosis in two of four GBM cultures
tested and decreases GBM cancer stem cell clonogenicity
in one of them. We conclude that HOP is a new regulator
of stem cell survival in the adult brain and that its deregu-
lation may participate in the tumorigenic process.
Results
SGL radial astrocytic stem cells in the hippocampus 
express HOP
To localize HOP expression in detail in stem cell niches of
the adult mouse brain, we performed in situ hybridization
and immunolocalization studies. HOP mRNA and pro-
tein were not detected in the SVZ of the lateral ventricle of
the adult forebrain. In contrast, they were found in the DG
and, in particular, in cells of the SGL (Figure 1a,b). The
specificity of the immunolabeling with the anti-HOP anti-
body that we raised was proven by the lack of staining in
the SGL of the HOP-/- mice [3] that survive the embryonic
period (Figure 1c). Immunoblots of the hippocampus
detected a single band at the expected size of 8 kDa, which
was absent in HOP-/- mice (Figure 1d).
The identity of HOP+ cells was determined by double-
labeling with glial fibrillary acidic protein (GFAP), a gen-
eral marker of astrocytes (Figure 1e–h). HOP+ cells were
found to be GFAP+ astrocytes, with SGL radial astrocytes
displaying the highest levels. Use of a second marker, 3-
phosphoglycerate dehydrogenase (3PGDH), which stains
the cell bodies and processes of all astrocytes, including
DG radial astrocytes [23], showed that all HOP+ cells were
3PGDH+, thus confirming their astrocytic identity (Figure
1i–l).
SGL radial astrocytes give rise to immature neuronal pre-
cursors (D or type 2 cells), which are nested along astro-
cytic processes [16] and express doublecortin (DCX)
[24,25]. Double immuno-staining with HOP and DCX
showed that these cells do not express HOP (Figure 1m–
p). Together, these results demonstrate that HOP  is
expressed by SGL radial astrocytes, which are neural stem
cells in the adult hippocampus.
HOP does not regulate the proliferation of SGL 
hippocampal stem cells
Given that adult neurogenesis requires proliferation and
survival of stem cells and their progeny, we tested the role
of HOP in these two processes.
HOP immunoreactive cells divide, as shown by short term
(2 h) bromodeoxyuridine (BrdU) incorporation (Figure
2a–c), as described previously for SGL astrocytes
[17,19,23]. We therefore tested whether HOP could regu-
late proliferation of SGL astrocytes by comparing the
number of BrdU+/GFAP+ in wild-type and HOP-/- mice (n
= 5). No significant differences were detected (Figure 2d).
Moreover, no differences were observed between wild-
type and HOP-/- mice even after infusion of basic fibrob-
last growth factor (bFGF) and epidermal growth factor
(EGF) to stimulate cell proliferation (n = 5; Figure 2e).
This result was confirmed by comparing the number ofNeural Development 2008, 3:13 http://www.neuraldevelopment.com/content/3/1/13
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HOP is expressed by SGL radial astrocytes Figure 1
HOP is expressed by SGL radial astrocytes. (a) In situ hybridization shows HOP mRNA expression in numerous DG cells with 
a prominent labeling in the SGL (arrow), the neurogenic region for the production of granule cells destined to the granule cell 
layer (GCL). (b) Immunohistochemical detection of HOP protein in the DG, especially in the SGL. WT, wild type. (c) HOP 
immunohistochemical staining is absent in knock out (KO) mice, demonstrating HOP antibody specificity. (d) Western blot 
shows an 8 kDa protein from hippocampal wild-type extracts, which is absent in the knock out extracts. (e-h) Double-staining 
with HOP and GFAP antibodies, illustrating the co-expression of the two proteins. (h) Higher magnification of the boxed area 
in (e-g) with orthogonal projections along the z confocal stack at the x and y levels indicated by the intersecting white lines. (i-
l) Double-staining with HOP and 3PGDH antibodies, showing that HOP immunoreactive cells are 3PGDH+. (l) Higher magnifi-
cation of the boxed area with orthogonal projections. (m-p) Double-staining with HOP and DCX, showing that they are 
expressed by different SGL cells. (p) Higher magnification of the boxed area with orthogonal projections. The y projection 
shows, in particular, that DCX+ processes are closely juxtaposed to HOP+ processes but are distinct. Scale bars: (a-f, e-g, i-k, 
m-p), 50 μm; (h, l, p), 10 μm.Neural Development 2008, 3:13 http://www.neuraldevelopment.com/content/3/1/13
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HOP does not regulate the proliferation of SGL astrocytic stem cells Figure 2
HOP does not regulate the proliferation of SGL astrocytic stem cells. (a-c) After a 2 h pulse of BrdU, mice were processed for 
HOP/BrdU immunocytochemistry. Some HOP immunoreactive cells incorporate BrdU. Scale bar: 10 μm. (d, e) After a 2 h 
pulse of BrdU, mice were processed for GFAP/BrdU ICC and the double-labeled SGL cells were counted under a confocal 
microscope (n = 5). The data are presented as the number of GFAP/BrdU cells per mm of SGL. The number of GFAP/BrdU 
cells is unchanged in the HOP knock out mice compared to the wild type (d) even when growth factors (EGF + bFGF, 20 μg/ml) 
were infused into the lateral ventricle to stimulate the proliferation of DG progenitors (n = 5) (e). (f-h) HOP (g) or control (f) 
siRNA coupled to the cell permeant peptide Penetratin (20 μM) were infused for three days above the DG to locally silence 
HOP expression. A strong reduction of HOP expression is seen after HOP siRNA infusion. (h) The number of GFAP/BrdU cells 
is not significantly different between the two conditions (n = 5). Scale bars: 50 μm.
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3PGDH+/BrdU+ cells in wild-type and HOP-/- mice (Addi-
tional file 1).
To confirm and extend this result, we knocked-down HOP
in wild-type mice through RNA interference using cell-
permeable small interfering RNAs (siRNAs). These siRNAs
were rendered cell-permeable by reversibly coupling them
to Penetratin, a small transducing peptide [26]. The
disulfide bond linking the siRNA and Penetratin is broken
in the intracellular context, allowing the siRNA to work in
the nucleus [27]. Infusing HOP siRNA-Penetratin into the
brain, at a location just above the DG with micro-osmotic
pumps, led to a dramatic reduction in HOP immunoreac-
tivity (Figure 2g) in the hippocampus, compared to the
infusion of a control Penetratin-coupled siRNA (Figure
2f). Semi-quantification of the optical density revealed
that HOP signal was reduced by 78% ± 5 standard error of
the mean (SEM; n = 5). To avoid any possible non-specific
effects due to direct injection damage of the DG, the infu-
sions were repeated at a distance, into the lateral ventricle,
and diffusion into the hippocampus was verified with a
fluorescent siRNA. Lateral ventricle infusions of HOP
siRNA resulted in a decrease of the optical density by 39%
± 3 SEM (n = 5), as compared with control siRNA infu-
sions.  HOP-siRNA and control siRNA-treated mice
infused for three days in the lateral ventricle showed sim-
ilar levels of BrdU incorporation in SGL GFAP+ stem cells
(Figure 2h). We conclude that HOP does not control the
proliferation of hippocampal stem cells.
Hippocampal SGL stem cell survival requires HOP 
function
To evaluate a possible role of HOP in stem cell survival,
we analyzed the number of TUNEL+ SGL cells in wild-type
and HOP-/- mice (Figure 3a,b). We found that loss of HOP
reduced the number of apoptotic SGL cells by more than
HOP regulates apoptosis of SGL astrocytic stem cells Figure 3
HOP regulates apoptosis of SGL astrocytic stem cells. (a) Apoptotic cells are detected in the SGL (arrows) with a TUNEL fluorescent assay. These cells 
are relatively rare (asterisks). Scale bar: 50 μm. (b) The number of TUNEL positive apoptotic cells in the SGL was counted across the entire DG (36 slices 
per mouse). A significant decrease of 48.2% is observed in knock out (KO) mice compared to wild type (WT) (n = 5, Mann-Whitney U test, *p = 0.001). 
(c-h) Double labeling for HOP and TUNEL shows that a majority of the TUNEL positive SGL cells are HOP immunoreactive (arrows). The arrowhead in 
(c-e) indicates a HOP negative TUNEL positive SGL cells (probably a D/type2 cell). The asterisk in (c-e) shows a TUNEL positive cell in the granule cell 
layer (probably a granular neuron). (i) Higher magnification of (h) with orthogonal projections along the z confocal stack at the x and y levels indicated by 
the intersecting white lines. Scale bars: 10 μm.Neural Development 2008, 3:13 http://www.neuraldevelopment.com/content/3/1/13
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two-fold (Figure 3b; n = 5, Mann-Whitney U  test, p  =
0.001). The amount of TUNEL+ cells expressing HOP was
82% ± 4 SEM (223 cells of 3 animals), indicating their
SGL astrocytic and thus stem cell nature (Figure 3c–i).
TUNEL+/HOP- cells are likely to be committed neuronal
precursors (D/type 2 cells) or neurons, which are nor-
mally pruned [28]. Given that a large majority of apop-
totic SGL cells in wild-type animals are HOP+ and that this
number is reduced in the absence of HOP, we conclude
that HOP is a pro-apoptotic factor in SGL radial astrocytic
stem cells in the hippocampus.
HOP regulates granule neuron production in the 
hippocampus
An effect in stem cell survival should be reflected on the
rate of production of new neurons. To assess this possibil-
ity, wild-type and HOP-/- mice were pulsed with BrdU fol-
lowed by a chase for three weeks before analyzing the
number of new BrdU+/NeuN+ DG neurons (Figure 4a,b),
as NeuN selectively marks differentiated neurons but not
progenitors. We found that the number of newly formed
neurons was 2.5-fold higher in the absence of HOP com-
pared to wild-type animals (Figure 4c; n = 6, Mann-Whit-
ney U test, p < 0.01).
This result could be due to a function of HOP in SGL adult
cells or to indirect effects, perhaps through an earlier effect
of HOP. Indeed, only 50% of HOP-/- animals survive to
adulthood [1,2]. Thus, to resolve between these two pos-
sibilities, we tested the effects of an acute knock-down of
HOP in the hippocampus of adult mice through RNA
interference with cell-permeable siRNAs as described
above. After three days of siRNA-Penetratin infusions,
mice were pulsed with BrdU and kept for an additional
three weeks to be able to assess newly formed neurons in
the DG. This treatment led to a 1.7-fold increase in the
number of newly formed NeuN+/BrdU+ neurons in mice
infused with HOP siRNA compared to mice infused with
a control siRNA (Figure 4d; n = 5, Mann-Whitney U test, p
< 0.01). The lower penetrance of the RNA interference
phenotype (1.7-fold) versus that seen in knock out mice
(2.5-fold) is consistent with the common incomplete
effects of RNA interference compared with gene deletions.
Notwithstanding this difference, the data support a direct
role of HOP in the regulation of hippocampal stem cell
apoptosis.
Human glioblastomas display low levels of HOP 
expression
Faulty apoptotic control of stem cell lineages could under-
lie or favor the development of tumors. Gliomas are com-
mon adult human brain tumors that are thought to
derive, at least in part, from stem cell lineages and harbor
cancer stem cells [20-22,29,30]. We thus tested the possi-
bility that loss of HOP, which decreases apoptosis in the
normal mouse hippocampal stem cell niche, marks
human gliomas. Here we have focused on grade IV astro-
cytomas (or GBMs), which are the most aggressive and
invasive type of gliomas and display poor prognosis.
Analysis by quantitative RT-PCR of four independent
glioblastomas [30] (GBM-6, -7, -8, -10) showed that HOP
HOP influences neuronal production Figure 4
HOP influences neuronal production. (a-c) Wild-type (WT) and knock out (KO) mice were injected three times with BrdU 
(30 mg/kg) three weeks before perfusion and double staining was performed with NeuN and BrdU to visualize newly formed 
neurons in the granule cell layer. Double-labeled cells were counted under a confocal microscope (a, b) and the data are pre-
sented as the number of NeuN/BrdU positive cells per mm of SGL (c). The number of newly formed NeuN/BrdU neurons is 
significantly higher (2.5-fold) in knock out mice than in wild type (n = 6, Mann-Whitney U test, *p < 0.01). (d) HOP or control 
siRNA were infused above the DG for three days before three injections of BrdU. Three weeks later, the number of newly 
formed NeuN/BrdU neurons was significantly higher (1.7-fold) in the HOP siRNA infused mice (n = 5, Mann-Whitney U test, *p 
< 0.01). Scale bars: 50 μm.Neural Development 2008, 3:13 http://www.neuraldevelopment.com/content/3/1/13
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mRNA is down-regulated in tumor excisions compared to
the normal cortex (Figure 5a). Nine normal brain samples
were used: one sample of hippocampus from an adult
donor, four samples of prefrontal cortex from different
adult donors; three samples from the same child donor
from three different regions of the cortex (frontal, parietal
and temporal); and one commercial sample of total adult
brain RNA. On average, expression of HOP was higher in
normal samples than in glioma resections. Given the
highly invasive nature of GBMs, surgically removed
tumors are bound to contain a high proportion of normal
brain cells. We thus measured HOP mRNA expression in
glioma neurosphere cultures (gliomaspheres), derived
from the same matched excision samples [30]. These cul-
tures contain and are driven by self-renewing cancer stem
cells and are tumorigenic, mimicking the original tumor
after transplantation into the brain of nude mice [30,31].
HOP mRNA expression was very low in the four GBM
stem cell cultures (Figure 5a). It was also extremely low in
U87 GBM cells. HOP mRNA levels were higher in two
other gliomasphere cultures (GBM-11 and -12), but we
could unfortunately not compare these levels to the
matched biopsies. Interestingly, the HOP expression level
was also extremely low in one oligodendroglioma and
corresponding gliomasphere culture. There is thus a posi-
HOP in gliomas and gliomaspheres Figure 5
HOP in gliomas and gliomaspheres. (a) Expression levels of HOP in control cortical tissues (black bars), fresh glioma samples 
(blue bars), culture of gliomaspheres (red bars) or U87 cells (green bars). The data are expressed as the relative ratio of HOP 
expression over that of GAPDH times 105. (b) Mouse HOP tagged with hemagglutinin (HOP-HA) and coupled to Penetratin 
was added to the medium of gliomaspheres from GBM-6 cells at 1 μM and the HA staining was developed. Cells are counter-
stained with Hoechst. Scale bar: 5 μm.Neural Development 2008, 3:13 http://www.neuraldevelopment.com/content/3/1/13
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tive trend correlating low levels of HOP and glioma stem
cell lineages in a subset of gliomas.
Increased HOP function decreases the survival, but not the 
proliferation, of a subset of human GBM stem cell lineages
To assess HOP function in GBM cells, we increased HOP
function by introducing cell-permeable HOP. Purified
full-length HOP protein, which itself is not cell permea-
ble, was coupled with Penetratin peptide, thus rendering
it cell permeable and functional in GBM cells after inter-
nalization (Figure 5b). As control, we used the homeodo-
main of Knotted (Kn-HD), a plant homeoprotein, which
can naturally penetrate into cells [32]. Analysis of Ki67+
cycling cells in GMB-6 stem cell cultures showed no differ-
ence in the percentage of proliferating cells after internal-
ization of HOP-Penetratin versus Kn-HD (8.72% ± 0.75
SEM versus 8.53% ± 0.72 SEM). In contrast, HOP inter-
nalization triggered a 50% increase in apoptosis, as meas-
ured by the percentage of apoptotic cleaved-Caspase 3+
cells compared to Kn-HD (13.9% ± 1.1 SEM versus 9.81%
± 0.87 SEM; p  = 0.0001). Restored HOP function in
human GBM-6 stem cell lineages is thus able to induce
apoptosis without affecting proliferation. Similarly, HOP-
Penetratin increased apoptosis in GBM-11 cells, which
express high levels of HOP, compared with Kn-HD (10%
± 0.9 SEM versus 5.81% ± 0.46 SEM; p = 0.05), whereas no
difference in their proliferation was measured by Ki67
staining (1.76% ± 0.05 SEM versus 1.7% ± 0.12 SEM). In
contrast, still in comparison with Kn-HD, HOP-Pene-
tratin did not modify apoptosis in GBM-8 cells (9.7 ± 1.31
SEM versus 7.63 ± 1.05 SEM; p = 0.24), which express low
levels of HOP, or in GBM-12 cells (3.75% ± 1.4 SEM ver-
sus 3.29% ± 0.47 SEM), which express higher levels. This
also confirmed the lack of non-specific effects of HOP-
Penetratin in GBM cells. HOP is thus able to induce apop-
totic cell death only in a subset of gliomaspheres with var-
ying levels of endogenous HOP. Analyses of the growth
rates of these cultures revealed that HOP was effective
only in those that grew poorly: GBM-12 gliomasphere cul-
tures had three times more cells than GBM-6 or GBM-11
cultures after six days under identical conditions and start-
ing with the same number of cells (M Vukicekic and ARA,
unpublished). The basis of this difference is not known.
HOP regulates the self-renewal of apoptosis-sensitive 
glioma cancer stem cells
To test if HOP could affect stem cell self-renewal, we used
GMB-6 cells that show a clear increase in apoptosis when
treated with HOP-Penetratin. GMB-6 gliomaspheres were
treated as above but in suspension to allow internaliza-
tion of HOP-Penetratin or Kn-HD as control and to be
able to plate one cell per well in 96-well plates. After two
weeks of growth, gliomaspheres were counted in tripli-
cates assays. It should be noted that clonal analyses of
glioblastoma cells is stringent even in the presence of 50%
conditioned media since these cells do not readily grow in
isolation. HOP induced a ten-fold reduction in the
number of clonogenic units (gliomaspheres) compared
with Kn-HD (0.3% ± 0.32 SEM versus 3% ± 0 SEM; p =
0.01). HOP is thus able to induce apoptosis of glioma
stem cells and decrease clonogenicity, used here as a
measure of self-renewal.
Discussion
We find that HOP is expressed in the adult hippocampal
stem cell niche from E14.5 to adulthood. Expression is in
all DG astrocytes and at high levels in SGL radial astro-
cytes. HOP protein is not detected in the adult SVZ, the
second site of adult neurogenesis, but it is present in Berg-
mann glial cells in the cerebellum (data not shown), the
only other radial astrocytes in the adult brain, confirming
and extending previous mRNA localization data [33].
We describe here a new mode of regulation of adult hip-
pocampal neurogenesis through modulation of adult pro-
genitor death. A recent study has shown that 85% of the
variance in neurogenesis between strains could be
explained by different cell-survival rates [34]. However,
attention has been focused on newly formed neurons in
the olfactory bulb [8,9] or DG [10,11,28], but not on their
progenitors. In contrast, developmental studies have
established that apoptosis contributes to the number of
neural stem cells and progenitors [12,13]. In the adult
brain, apoptotic cells are present in the SVZ and SGL [14],
and, in the SVZ, some of these apoptotic cells are astro-
cytes [35]. A role for apoptosis on the regulation of SVZ
stem cells is also suggested by their enhanced number in
mice deficient for the pro-apoptotic genes Bax and Bak
[36]. Our work extends this concept to adult DG stem cells
and, furthermore, identifies HOP as a positive regulator of
apoptosis in these cells.
As fewer hippocampal progenitors die in mice lacking
HOP, one could predict that loss of HOP may lead to a
change of the total number of progenitors. However, the
number of GFAP+/BrdU+ cells (reflecting the number of
progenitors) is the same in HOP null and wild-type sib-
lings (Figure 2b). We have also counted the number of
SGL cells expressing Sox2, a marker of actively dividing
astrocytic DG progenitors [37], and found no difference
in the number of Sox2+ SGL cells between wild-type and
HOP null mice (not shown). The reduction of hippocam-
pal progenitor death in mice lacking HOP, therefore, does
not lead to an increase in their number. A reduction in
progenitor death not leading to an increase in their abun-
dance is puzzling, although it could be explained by a dif-
ference in the choice between symmetric and asymmetric
divisions in wild-type versus HOP null hippocampal stem
cells. Indeed, GBM cells that increase apoptosis in
response to enhanced HOP levels also decrease their self-Neural Development 2008, 3:13 http://www.neuraldevelopment.com/content/3/1/13
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renewal (as measured by their clonogenicity). Therefore,
there may be a mechanism that senses overall cell num-
bers and that regulates self-renewal and apoptosis in nor-
mal and tumorigenic stem cell lineages.
HOP has been shown to interact with SRF in the heart
[1,2] where it acts as an inhibitor of SRF transcriptional
activity. Specific SRF invalidation leads to embryonic
lethal cardiac defects [38-40]. These mice display an
abnormally thin myocardium due to increased apoptosis
without changes in proliferation. This result is consistent
with ours, suggesting that HOP in radial DG progenitors
may bind SRF and inhibit its activity We have started to
investigate this possibility and find that HOP is co-immu-
noprecipitated with SRF from hippocampal extracts
(Additional file 2). It is also known that SRF promotes cell
survival by activating the expression of the anti-apoptotic
gene Bcl2 in embryonic stem cell and early embryogenesis
[41]. One could thus hypothesize that HOP acts in DG
progenitors by inhibiting SRF activation of the Bcl2 gene.
We tried to test this hypothesis by comparing Bcl2 expres-
sion in wild-type and knock out mice by quantitative RT-
PCR but since the vast majority of hippocampal cells
express Bcl2, a potential difference in a minority of pro-
genitors could not be quantified.
The deregulation of apoptosis in hippocampal stem cells
could contribute to dysfunction and/or disease. We report
a common down-regulation of HOP in glioma excisions
(which contain both tumor and normal surrounding tis-
sues) compared to controls and even lower levels of HOP
in gliomaspheres (which only contain tumor-derived can-
cer stem cell lineages). Experimentally, increased HOP
expression enhanced apoptosis in a subset of gliomas-
phere cultures. Differences in responsiveness to HOP
might depend, for instance, on the region of origin of the
tumor or on the presence of co-factors necessary for HOP
pro-apoptotic function. The apoptotic-inducing activity of
HOP, albeit context-dependent, may be related to its nor-
mal function, as brain tumors are thought to derive from
the transformation of stem cells and/or progenitors in
adult neurogenic regions. Indeed, alterations in the cellu-
lar mechanisms that control adult neurogenesis might
contribute to tumorigenesis [20-22]. This is consistent
with different studies describing HOP as a possible tumor
suppressor because of its down-regulation in choriocarci-
noma [5], head and neck squamous cell carcinoma [4]
and lung cancer [3]. HOP might thus participate in the
regulation of stem cell behavior both in normal and in
tumorigenic contexts.
Conclusion
We describe here a new function for the homeoprotein
HOP as a negative regulator of hippocampal stem cell sur-
vival. Our work provides the first evidence that apoptosis
of stem cells can regulate adult neurogenesis. In addition,
HOP expression is low in gliomas and its re-expression in
gliomaspheres induces apoptosis and a reduction of gli-
oma cancer stem cell self-renewal in a subset of cases. We
suggest that HOP acts as a tumor suppressor in the hip-
pocampal stem cell niche, where its loss could favor the
inappropriate survival of stem cells and their descendants,
increasing cell numbers and contributing thus to tumor
growth.
Materials and methods
HOP cloning and antibody production
HOP cDNA was cloned from hippocampal mRNA and
subcloned into pGEM vectors for riboprobe synthesis and
pGEX vectors for protein production. The recombinant
HOP protein was purified and used to produce a rabbit
polyclonal antibody (Animal Pharm Services, Healds-
burg, CA, USA).
Histology
The mice used were either Swiss or the HOP knock out
mice from the Epstein laboratory [1] analyzed along with
control wild-type littermates.
For immunostaining, in situ hybridization and TUNEL
staining, adult mice (two months old) were perfused (4%
paraformaldehyde), their brains were removed, post-fixed
overnight and sectioned with a vibratome (frontal sec-
tions, 50 μm thick).
Immunostaining and in situ hybridization
Sections were blocked in phosphate-buffered saline, 10%
fetal calf serum, 0.3% triton and incubated in primary
antibodies in the same buffer for 36 h at 4°C under agita-
tion. Antibodies were mouse anti-GFAP (1:1,000; Sigma-
Aldrich, Lyon, France), rat anti-BrdU (1:1,000; Accurate
Chemicals, Westbury, NY, USA), mouse anti-NeuN
(1:1,000; Millipore, Saint Quentin en Yvelines, France,
rabbit anti-SRF (1:500; Santa Cruz Biotechnology, Santa
Cruz, CA, USA), rabbit anti-Sox2 (1:2,000; Millipore),
guinea-pig anti-3PGDH (1:200; Frontier Science,
Hokkaido, Japan), guinea-pig anti-Dcx (1:1,000; Milli-
pore) Fluorescent secondary antibodies were FITC, rhod-
amine or Cy3 anti-species (1:1,000; Jackson
Immunoresearch, Suffolk, UK). Immuno-labeled sections
were observed and imaged with confocal Leica and Zeiss
microscopes and a compound Axiophot microscope. In
situ hybridizations were performed as described [42].
TUNEL staining
Sections were dehydrated in successive baths of 50%,
70%, 90%, and 100% ethanol followed by rehydration
along the inverse path. They were then incubated in the
TUNEL (terminal deoxynucleotidyl transferase biotin-
dUTP nick end labeling) staining mix of the Roche kitNeural Development 2008, 3:13 http://www.neuraldevelopment.com/content/3/1/13
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(Roche Diagnostics, Meylan, France) according to the
manufacturer's instructions, thus leading to a FITC stain-
ing of apoptotic cells
siRNA-Penetratin coupling
The sequence of the sense strand of HOP siRNA is: AAG-
GCTTGCCTTCGGAATGCA. It was produced by Qiagen
(Courtaboeuf, France) with a thiol modification on the 5'
extremity of the sense strand. Annealed siRNA duplex was
resuspended in the buffer provided by the manufaturer
and heated at 90°C for 1 minute followed by a 1 h incu-
bation at 37°C. It was then pretreated with an equimolar
quantity of TCEP for 5 minutes at room temperature. An
equimolar amount of activated penetratin was added and
the reaction was allowed for 2 h at 37°C. The efficacy of
the coupling was assessed on 22% polyacrylamide gel
with and without dithiothreitol. The control siRNA was
the standard control siRNA from Qiagen called Negative.
Brain infusions
Coupled siRNAs (20 μM) or growth factors (EGF + bFGF,
20 μg/ml) were diluted in 0.09% NaCl. Mice were infused
continuously for three days using micro-osmotic pumps
(1  μl/h, model 1003, Alzet, Cupertino, CA, USA)
implanted streotaxically. The coordinates for intraven-
tricular infusion of growth factors were: anterior/poste-
rior, 0; lateral, 0.8 mm;depth, 2 mm (relative to bregma
and surface of the brain). The coordinates for intraven-
tricular infusion of siRNAs were: anterior/posterior, -0.82
mm; lateral, 1.5 mm; depth, 1.7 mm. The coordinates for
intraventricular infusion of siRNA above the DG were:
anterior/posterior, -2.46; lateral, 0.7 mm;depth, 2 mm.
Quantitative analyses
At least five mice per condition were used. Statistical sig-
nificance was determined using Mann-Whitney U  test.
After perfusion, the region of the brain containing the DG
was cut frontally with a vibratome as four alternate series
of nine 50 μm thick sections. For the proliferation assay,
mice were injected intraperitoneally with BrdU (30 mg/
kg) and perfused 2 h later. One of the four series of sec-
tions was immunohistochemically labeled with GFAP
and BrdU. The sections were observed under the 20×
objective of a Leica confocal microscope and all BrdU pos-
itive cells located in the SGL were zoomed upon (magni-
fication of at least 5 times) and observed along the z-axis
to assess their GFAP immunoreactivity. The DG length of
each section was measured with NIH image and the total
number of GFAP/BrdU positive cells of all sections was
divided by this length to be expressed as GFAP/BrdU pos-
itive cells per DG length. For neuronal production, mice
were injected intraperitoneally 3 times every 3 h with
BrdU (30 mg/kg), perfused 3 weeks later and the quantifi-
cation was performed as above after a NeuN/BrdU immu-
nocytochemistry (ICC). For TUNEL staining, all 36 DG
sections of each animal were processed and the total
number of TUNEL positive SGL cells counted with the
Leica SP2 confocal microscope.
To assess the reduction of immunoreactivity after siRNA
infusions, the optical density of one series of sections per
animal was measured with ImageJ as the mean gray value
within the DG.
Glioma tissues and stem cell cultures
Human glioma samples were obtained from the Hôpital
Universitaire de Genève under approved protocols as in
Clement  et al. [30]. Glioma stem cell cultures were
obtained by dissociating the fresh tumor sample from the
operating room in 3 mg/ml Papain for 45–90 minutes fol-
lowed by overnight culture in DMEM-F12, 20% BIT (Stem
Cell Technologies, Grenoble, France), 1% penicillin-strep-
tomycin. The cultures were then centrifuged, washed and
cultured in full media (the same media as above plus 50%
conditioned media from other gliomasphere cultures and
10 μg/ml each of recombinant bFGF and EGF). Manipula-
tion of gliomaspheres was as in Clement et al. [30]. GBM
U87 cells (ATCC, Molsheim, France) were grown as sug-
gested by the supplier. Total human brain RNA was pur-
chased from Yorkshire Biosciences Ltd (Heslington, York
UK).
For internalization, gliomaspheres were cultured on poly-
ornithine and poly-laminine coated wells and HOP cou-
pled to Penetratin (Hop-Penetratin) or Knotted homeo-
domain were added to the medium at 1 μM (six wells per
condition, repeated two times). After 48 h, cells were fixed
with 4% paraformaldehyde and stained with rabbit anti-
activated Caspase-3 (Cell Signaling, Beverly, MA, USA) or
mouse anti-Ki-67 (Transduction Laboratory, Lexington,
NY, USA). Stained cells were counted with a Zeiss Axio-
phot optical microscope.
For cloning assays, gliomaspheres were dissociated manu-
ally with a 200 μl tip. Dissociated cells were then treated
with HOP-Penetratin or controls for 48 h before plating in
full media in 96-well plates at a density of one cell per
well. Fourteen days after plating, gliomasphere growth
was scored visually under the microscope.
Real time quantitative RT-PCR
Quantitative real time RT-PCR was performed using the
iQ™ SYBR Green supermix (Biorad, Hercules, CA, USA) at
60°C, according to the manufacturer's instructions. Prim-
ers were 5' to 3': HOP-s, ACCACGCTGTGCCTCATC;
HOP-a, TTGGTTAAGCGGAGGAGAGA; GAPDH-s, TGA-
CATCAAGAAGGTGGTGAAGC;  GAPDH-a, CCCTGTT-
GCTGTAGCCGTATTC.Neural Development 2008, 3:13 http://www.neuraldevelopment.com/content/3/1/13
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